Are you storing your products properly?

Proper storage of pharmaceuticals is another critical component of your GMP processes. Finished products as well as raw materials must be stored in proper containers, in temperature-controlled environments in order to maintain their integrity as well as their stability.

According to 21 CFR 211.142(b), written procedures describing the warehousing of drug products shall be established and followed. They should include quarantine of drug products before release by the quality control unit and storage of drug products under appropriate conditions of temperature, humidity, and light so that the identity, strength, quality, and purity of the drug products are not affected.

A company recently received this 483 observation:

ā€¦ Drug products are not stored under appropriate conditions of so that their identity, strength, quality, and purity are not affected.

 Specifically.

a.              The temperature mapping studies for the Finished Goods Warehouse and the Raw Materials Warehouse (protocol # …. ) were conducted in the fall over a limited period of 24 hours. The outside temperature during these studies were not documented to show that these studies were conducted during the representative worst case outside temperatures.

b.             We observed packaged finished drug products that were stored in the Components Warehouse that is not temperature monitored. Multiple finished drug products were found stored in the non-temperature controlled Components Warehouse.

c.              We observed excipient … lot # … with a stated storage condition of …  stored in the raw materials warehouse that has temperature specification limit of …

d.             Reserve samples are stored in a room that also stores various materials in boxes from the last 10 years. Several of these boxes were found to be leaking materials, soiling the storage racks adjacent to the reserve sample racks, and the floor of the room.

For more observationsĀ pertaining to proper storage of pharmaceuticals and manufacturingĀ controls, seeĀ Issue 1051Ā available today.Ā  It also has observations pertaining to laboratory controls, API manufacturers and medical device manufacturers.

Stay in Compliance!Ā SubscribeĀ today!

Become A Subscriber And Stay Ahead of the FDA

To get the most out of GMP TrendsĀ®, sign up to one of our subscription packages for valuable, up-to-date information you won't find anywhere else! Every subscription provides the most frequently cited FDA 483 observations taken from recent FDA Inspections. The non-essential information is redacted to streamline the facts in an easily readable format. Join the thousands of professionals who rely on GMP TrendsĀ® to keep them informed of the latest FDA Enforcement Trends!

SUBSCRIBE NOW